| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ROBBINS LARRY | Director | 767 FIFTH AVENUE, 44TH FLOOR, NEW YORK | /s/ Larry Robbins | 2025-11-21 | 0001228603 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BFLY | Class A Common Stock | Purchase | $2.35M | +1M | +10.05% | $2.35 | 11M | Nov 19, 2025 | See footnotes | F1, F2, F5, F7 |
| transaction | BFLY | Class A Common Stock | Purchase | $2.37M | +1M | +9.13% | $2.37 | 12M | Nov 20, 2025 | See footnotes | F1, F3, F5, F7 |
| transaction | BFLY | Class A Common Stock | Purchase | $2.06M | +800K | +6.69% | $2.58 | 12.8M | Nov 21, 2025 | See footnotes | F1, F4, F5, F7 |
| holding | BFLY | Class A Common Stock | 4.55M | Nov 19, 2025 | See footnotes | F6, F7 | |||||
| holding | BFLY | Class A Common Stock | 366K | Nov 19, 2025 | Direct | F8 |
| Id | Content |
|---|---|
| F1 | These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (collectively, the "Glenview Investment Funds"). |
| F2 | This price reflects the weighted average price for open-market purchases of Shares on November 19, 2025 within a $1.00 range. The actual prices for these transactions range from $2.0137 to $2.50, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. |
| F3 | This price reflects the weighted average price for open-market purchases of Shares on November 20, 2025 within a $1.00 range. The actual prices for these transactions range from $2.305 to $2.43, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. |
| F4 | This price reflects the weighted average price for open-market purchases of Shares on November 21, 2025 within a $1.00 range. The actual prices for these transactions range from $2.355 to $2.65, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. |
| F5 | The Glenview Investment Funds are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares. |
| F6 | Longview Investors LLC ("Longview"), or its affiliates, is the record holder of these securities. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the securities held by Longview and may be deemed to beneficially own such securities. |
| F7 | Mr. Robbins disclaims beneficial ownership over any securities owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. |
| F8 | Includes 80,434 unvested restricted stock units ("RSUs"). Each RSU represents the right to receive one Share upon vesting. The RSUs vest in full on the date of the Issuer's 2026 Annual Stockholders Meeting, subject to Mr. Robbins' continued service on the Board of Directors on such date. |